Natco receives Generic Daclatasvir approval for India
Natco Pharma Ltd has informed BSE regarding a Press Release dated December 14, 2015 titled "Natco receives Generic Daclatasvir approval for India".14-12-2015
14-12-2015
Natco settles patent case with Gilead, others over Tamiflu; shares rise
The settlement covers 30 mg, 45 mg and 75 mg versions of Tamiflu, generically called oseltamivir phosphate14-12-2015
Alvogen and Natco Settle Infringement Suit with Gilead and Others for Generic Tamiflu
Natco Pharma Ltd has submitted to BSE a copy of Press Release dated December 14, 2015 titled "Alvogen and Natco Settle Infringement Suit with Gilead and Others for Generic Tamiflu".14-12-2015
NATCO PHARMA LIMITED
Natco Pharma (NPL) is a vertically integrated and R&D; focused pharmaceutical company engaged in developing,manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). NPL's focus is primarily on niche therapeutic areas and complex products and it markets and distributes products in over...14-12-2015
Authorised KMPs to determine materiality of events/information
Natco Pharma Ltd has informed BSE regarding Details of Key Managerial Personnel ("KMP") for determining materiality under Regulation 30(5) of SEBI (Listing and obligation Disclosure Requirements) Regulations, 2015.02-12-2015
Natco Pharma suspends work at Chennai plant due to flood
Drug firm Natco Pharma today said its active pharmaceuticals ingredient plant at Chennai has suspended operations due to flooding caused by rains.02-12-2015
Natco Pharma's WOS API plant operations at Chennai temporarily suspended due to flooding
Natco Pharma Ltd has informed BSE regarding a Press Release dated December 02, 2015, titled "Natco Pharma's WOS API plant operations at Chennai temporarily suspended due to flooding".02-12-2015
Natco shareholders approve amalgamation of subsidiary with company
Drug firm Natco Pharma today said it has received shareholders' approval for amalgamation of its subsidiary Natco Organics into the company.30-11-2015
Results of Postal Ballot (Clause 35A)
Natco Pharma Ltd has informed BSE that the members of the Company have passed the resolution by way of Postal Ballot, under Clause 35A.30-11-2015
Natco Pharma turns ex-stock split; hits record high
The stock surged 16% to Rs 598, also its record high on the BSE.26-11-2015